English

Lykera biomed project

Lykera is a privately held biotech company based in Barcelona, Spain. The Company is developing biologics for the treatment of cancer by targeting not only the tumour cells but also the stromal cells and tumour angiogenesis.

Lykera's most advanced product, LK-1 is a first in class antibody against the three tumour compartments. LK-1 has already the in vivo preclinical proof-of-principle and it is ready to enter regulatory preclinical phases.

Lykera's vision stands for bringing innovative therapies for cancer treatment based on a global view of cancer. Innovation for future health.

Download presented posters @EACR22-2012,  #1053 & #1058

News

  • Peluang Usaha Es Krim

    8/09/2014

    Usaha es krim layak dicoba bagi Anda yang sedang galau mencari peluang usaha baru. Anda bisa memulai usaha ini dengan[…]

  • Peluang Usaha Keripik Buah Sangat Menjanjikan

    8/09/2014

    Peluang usaha keripik buah semakin menjanjikan. Bisnis ini termasuk bisnis yang mudah untuk memulainya. Dengan hanya bermodal mesin vacuum frying,[…]

Lykera biomed ┬ęcopyright 2011